Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients
Clinical trial NCT01640535 · COMPLETED
Trial details
- NCT number
- NCT01640535
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2013-02-01
- Enrollment
- 283
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.